Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by 29.0%, R&D Expenses Jumps Over 40% 2019-03-21 00:14
Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer 2019-03-20 18:27
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019 2019-03-20 16:00
P-MEC China to Arrive in June as Shanghai Gathers International Advanced Pharmaceutical Equipment 2019-03-20 15:00
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States 2019-03-19 18:00
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S. 2019-03-19 08:09
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1) 2019-03-18 20:45
CSPC Pharmaceutical Announces 2018 Annual Results 2019-03-18 12:18
Adlai Nortye's Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC 2019-03-15 17:06
Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology 2019-03-14 21:14
Innovent Announces 2018 Annual Results 2019-03-14 07:36
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA® 2019-03-13 17:00
CStone received IND approval in China for HDAC6 inhibitor CS3003 2019-03-13 10:10
Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer 2019-03-13 04:28
Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth 2019-03-12 19:00
Medtec China 2019 scales up by 21% with a strong increase in new exhibitors 2019-03-12 12:13
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing 2019-03-12 07:00
1 322 323 324 325 326 401